MaxCyte Inc (MXCT) stock news · rev $33.0M
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
This MXCT news page leads with what MaxCyte Inc filed — not a scraped headline mill.
No cached 8-K sentence for MXCT yet. We will not pad this page with generic market recap.
Latest reported MXCT revenue for 2025-12-31 was $33.0M. Net income was -$44.6M. Revenue was down 14.5% from 2024-12-31 to 2025-12-31. MXCT currently screens at market cap $124.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MXCT stock page; for the tape open the quote page.
MXCT stock news FAQ
What are MXCT's latest revenue and net income?
Latest cached MaxCyte Inc (MXCT) revenue for Dec 31, 2025 was $33.0M. Net income was -$44.6M. Statements: https://lician.com/financials/mxct
How did MXCT revenue change from the prior cached period?
Cached MaxCyte Inc (MXCT) revenue was down 14.5% from $38.6M (Dec 31, 2024) to $33.0M (Dec 31, 2025). Statements: https://lician.com/financials/mxct
What is MXCT's market cap?
MaxCyte Inc (MXCT) market cap is $124.3M on the latest cached fundamentals snapshot.
What kind of company is MXCT?
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Where is MXCT stock news listed?
Cached stock news for MaxCyte Inc (MXCT) is listed at https://lician.com/news/mxct. Filings: https://lician.com/sec/mxct
Not investment advice.